More on LENZ
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.25 |
|
|||
| Open | $3.23 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $3.23 | ||||
| Day Low | $3.06 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 696,454 | ||||
- LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
- Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: MILLENNIUM MANAGEMENT LLC
- LENZ Therapeutics Inc (LENZ) PT Lowered to $50 at TD Cowen
- LENZ Therapeutics Inc (LENZ) PT Lowered to $5 at Piper Sandler
- BofA Securities Downgrades LENZ Therapeutics Inc (LENZ) to Neutral
- LENZ Therapeutics Inc (LENZ) PT Lowered to $7 at Piper Sandler
- Citi cuts Lenz Therapeutics price target to $10 on slow sales
- LENZ Therapeutics, Inc. (LENZ) Tops Q2 EPS by 5c
- Form 10-Q LENZ Therapeutics, Inc. For: Jun 30
- Form 8-K LENZ Therapeutics, Inc. For: Aug 11
Entities mentioned with LENZ
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- Earnings | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
